chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 33.0
Sex: F
Vaccine: FLUN3, FLUN3
Symptoms: Blood culture negative, Blood glucose increased, Blood pH decreased, Blood urea decreased, Bronchoalveolar lavage normal
Clinical narrative: This is a follow-up to a previously submitted VAERS report unknown, received annual FLUMIST vaccination on 9/23/2010 (MED 501057P). She advised she had a mild cough with a sore scratchy throat for 2 days prior to this vaccination (exposed to friend with strep throat). By 9/26/2010 (3 days post vaccination) she began to experience a purulent productive cough that would wake her up, sweating, fever (greater than 102), shortness of breath (problems inhaling), and inability to sleep. She presented to nearby hospital the next morning 9/27/2010 (day 4 after FLUMIST vaccine and day 6 for symptom onset) and admitted for Community Acquired Pneumonia (CAP). On 9/29/2010, her respiratory status worsened and she complained of chest pain. She was transferred to hospital for emergent intubation (RR 50-60) being diagnosed with ARDS and multilobar bacterial community acquired pneumonia. She required use of high-frequency oscillatory ventilation, 14 days ceftriaxone and 12 days azithromycin, tracheostomy secondary to tongue angioedema unresponsive to steroids, two right chest tubes secondary to tension pneumothorax, and feeding tubes. On 10/22/2010 she was discharged for inpatient rehab with continued improvement and ultimate resolution of ARDS, multilobe bacterial pneumonia, tongue angioedema, dysphagia, debilitation, and severe malnutrition.
Age: 33.0
Sex: F
Vaccine: FLUN3, FLUN3
Symptoms: Carbon dioxide decreased, Chest X-ray abnormal, Chest pain, Chest tube insertion, Computerised tomogram thorax normal
Clinical narrative: This is a follow-up to a previously submitted VAERS report unknown, received annual FLUMIST vaccination on 9/23/2010 (MED 501057P). She advised she had a mild cough with a sore scratchy throat for 2 days prior to this vaccination (exposed to friend with strep throat). By 9/26/2010 (3 days post vaccination) she began to experience a purulent productive cough that would wake her up, sweating, fever (greater than 102), shortness of breath (problems inhaling), and inability to sleep. She presented to nearby hospital the next morning 9/27/2010 (day 4 after FLUMIST vaccine and day 6 for symptom onset) and admitted for Community Acquired Pneumonia (CAP). On 9/29/2010, her respiratory status worsened and she complained of chest pain. She was transferred to hospital for emergent intubation (RR 50-60) being diagnosed with ARDS and multilobar bacterial community acquired pneumonia. She required use of high-frequency oscillatory ventilation, 14 days ceftriaxone and 12 days azithromycin, tracheostomy secondary to tongue angioedema unresponsive to steroids, two right chest tubes secondary to tension pneumothorax, and feeding tubes. On 10/22/2010 she was discharged for inpatient rehab with continued improvement and ultimate resolution of ARDS, multilobe bacterial pneumonia, tongue angioedema, dysphagia, debilitation, and severe malnutrition.
Age: 33.0
Sex: F
Vaccine: FLUN3, FLUN3
Symptoms: Culture urine negative, Dysphagia, Dyspnoea, Echocardiogram normal, Electrocardiogram ST-T change
Clinical narrative: This is a follow-up to a previously submitted VAERS report unknown, received annual FLUMIST vaccination on 9/23/2010 (MED 501057P). She advised she had a mild cough with a sore scratchy throat for 2 days prior to this vaccination (exposed to friend with strep throat). By 9/26/2010 (3 days post vaccination) she began to experience a purulent productive cough that would wake her up, sweating, fever (greater than 102), shortness of breath (problems inhaling), and inability to sleep. She presented to nearby hospital the next morning 9/27/2010 (day 4 after FLUMIST vaccine and day 6 for symptom onset) and admitted for Community Acquired Pneumonia (CAP). On 9/29/2010, her respiratory status worsened and she complained of chest pain. She was transferred to hospital for emergent intubation (RR 50-60) being diagnosed with ARDS and multilobar bacterial community acquired pneumonia. She required use of high-frequency oscillatory ventilation, 14 days ceftriaxone and 12 days azithromycin, tracheostomy secondary to tongue angioedema unresponsive to steroids, two right chest tubes secondary to tension pneumothorax, and feeding tubes. On 10/22/2010 she was discharged for inpatient rehab with continued improvement and ultimate resolution of ARDS, multilobe bacterial pneumonia, tongue angioedema, dysphagia, debilitation, and severe malnutrition.
Age: 33.0
Sex: F
Vaccine: FLUN3, FLUN3
Symptoms: Electrocardiogram ST-T segment depression, Electrocardiogram T wave abnormal, Endotracheal intubation, Fibrin, Gastrointestinal tube insertion
Clinical narrative: This is a follow-up to a previously submitted VAERS report unknown, received annual FLUMIST vaccination on 9/23/2010 (MED 501057P). She advised she had a mild cough with a sore scratchy throat for 2 days prior to this vaccination (exposed to friend with strep throat). By 9/26/2010 (3 days post vaccination) she began to experience a purulent productive cough that would wake her up, sweating, fever (greater than 102), shortness of breath (problems inhaling), and inability to sleep. She presented to nearby hospital the next morning 9/27/2010 (day 4 after FLUMIST vaccine and day 6 for symptom onset) and admitted for Community Acquired Pneumonia (CAP). On 9/29/2010, her respiratory status worsened and she complained of chest pain. She was transferred to hospital for emergent intubation (RR 50-60) being diagnosed with ARDS and multilobar bacterial community acquired pneumonia. She required use of high-frequency oscillatory ventilation, 14 days ceftriaxone and 12 days azithromycin, tracheostomy secondary to tongue angioedema unresponsive to steroids, two right chest tubes secondary to tension pneumothorax, and feeding tubes. On 10/22/2010 she was discharged for inpatient rehab with continued improvement and ultimate resolution of ARDS, multilobe bacterial pneumonia, tongue angioedema, dysphagia, debilitation, and severe malnutrition.
Age: 33.0
Sex: F
Vaccine: FLUN3, FLUN3
Symptoms: Granulocyte percentage, Hyperhidrosis, Insomnia, Laboratory test normal, Legionella test
Clinical narrative: This is a follow-up to a previously submitted VAERS report unknown, received annual FLUMIST vaccination on 9/23/2010 (MED 501057P). She advised she had a mild cough with a sore scratchy throat for 2 days prior to this vaccination (exposed to friend with strep throat). By 9/26/2010 (3 days post vaccination) she began to experience a purulent productive cough that would wake her up, sweating, fever (greater than 102), shortness of breath (problems inhaling), and inability to sleep. She presented to nearby hospital the next morning 9/27/2010 (day 4 after FLUMIST vaccine and day 6 for symptom onset) and admitted for Community Acquired Pneumonia (CAP). On 9/29/2010, her respiratory status worsened and she complained of chest pain. She was transferred to hospital for emergent intubation (RR 50-60) being diagnosed with ARDS and multilobar bacterial community acquired pneumonia. She required use of high-frequency oscillatory ventilation, 14 days ceftriaxone and 12 days azithromycin, tracheostomy secondary to tongue angioedema unresponsive to steroids, two right chest tubes secondary to tension pneumothorax, and feeding tubes. On 10/22/2010 she was discharged for inpatient rehab with continued improvement and ultimate resolution of ARDS, multilobe bacterial pneumonia, tongue angioedema, dysphagia, debilitation, and severe malnutrition.
Age: 33.0
Sex: F
Vaccine: FLUN3, FLUN3
Symptoms: Liver function test normal, Lung infiltration, Lymphocyte percentage decreased, Malnutrition, Mechanical ventilation
Clinical narrative: This is a follow-up to a previously submitted VAERS report unknown, received annual FLUMIST vaccination on 9/23/2010 (MED 501057P). She advised she had a mild cough with a sore scratchy throat for 2 days prior to this vaccination (exposed to friend with strep throat). By 9/26/2010 (3 days post vaccination) she began to experience a purulent productive cough that would wake her up, sweating, fever (greater than 102), shortness of breath (problems inhaling), and inability to sleep. She presented to nearby hospital the next morning 9/27/2010 (day 4 after FLUMIST vaccine and day 6 for symptom onset) and admitted for Community Acquired Pneumonia (CAP). On 9/29/2010, her respiratory status worsened and she complained of chest pain. She was transferred to hospital for emergent intubation (RR 50-60) being diagnosed with ARDS and multilobar bacterial community acquired pneumonia. She required use of high-frequency oscillatory ventilation, 14 days ceftriaxone and 12 days azithromycin, tracheostomy secondary to tongue angioedema unresponsive to steroids, two right chest tubes secondary to tension pneumothorax, and feeding tubes. On 10/22/2010 she was discharged for inpatient rehab with continued improvement and ultimate resolution of ARDS, multilobe bacterial pneumonia, tongue angioedema, dysphagia, debilitation, and severe malnutrition.
Age: 33.0
Sex: F
Vaccine: FLUN3, FLUN3
Symptoms: Middle insomnia, PCO2, PO2, Pneumonia, Pneumonia bacterial
Clinical narrative: This is a follow-up to a previously submitted VAERS report unknown, received annual FLUMIST vaccination on 9/23/2010 (MED 501057P). She advised she had a mild cough with a sore scratchy throat for 2 days prior to this vaccination (exposed to friend with strep throat). By 9/26/2010 (3 days post vaccination) she began to experience a purulent productive cough that would wake her up, sweating, fever (greater than 102), shortness of breath (problems inhaling), and inability to sleep. She presented to nearby hospital the next morning 9/27/2010 (day 4 after FLUMIST vaccine and day 6 for symptom onset) and admitted for Community Acquired Pneumonia (CAP). On 9/29/2010, her respiratory status worsened and she complained of chest pain. She was transferred to hospital for emergent intubation (RR 50-60) being diagnosed with ARDS and multilobar bacterial community acquired pneumonia. She required use of high-frequency oscillatory ventilation, 14 days ceftriaxone and 12 days azithromycin, tracheostomy secondary to tongue angioedema unresponsive to steroids, two right chest tubes secondary to tension pneumothorax, and feeding tubes. On 10/22/2010 she was discharged for inpatient rehab with continued improvement and ultimate resolution of ARDS, multilobe bacterial pneumonia, tongue angioedema, dysphagia, debilitation, and severe malnutrition.
Age: 33.0
Sex: F
Vaccine: FLUN3, FLUN3
Symptoms: Pneumothorax, Productive cough, Protein total decreased, Prothrombin time, Purulent discharge
Clinical narrative: This is a follow-up to a previously submitted VAERS report unknown, received annual FLUMIST vaccination on 9/23/2010 (MED 501057P). She advised she had a mild cough with a sore scratchy throat for 2 days prior to this vaccination (exposed to friend with strep throat). By 9/26/2010 (3 days post vaccination) she began to experience a purulent productive cough that would wake her up, sweating, fever (greater than 102), shortness of breath (problems inhaling), and inability to sleep. She presented to nearby hospital the next morning 9/27/2010 (day 4 after FLUMIST vaccine and day 6 for symptom onset) and admitted for Community Acquired Pneumonia (CAP). On 9/29/2010, her respiratory status worsened and she complained of chest pain. She was transferred to hospital for emergent intubation (RR 50-60) being diagnosed with ARDS and multilobar bacterial community acquired pneumonia. She required use of high-frequency oscillatory ventilation, 14 days ceftriaxone and 12 days azithromycin, tracheostomy secondary to tongue angioedema unresponsive to steroids, two right chest tubes secondary to tension pneumothorax, and feeding tubes. On 10/22/2010 she was discharged for inpatient rehab with continued improvement and ultimate resolution of ARDS, multilobe bacterial pneumonia, tongue angioedema, dysphagia, debilitation, and severe malnutrition.
Age: 33.0
Sex: F
Vaccine: FLUN3, FLUN3
Symptoms: Pyrexia, Respiratory disorder, Sinus tachycardia, Streptococcus test negative, Tracheostomy
Clinical narrative: This is a follow-up to a previously submitted VAERS report unknown, received annual FLUMIST vaccination on 9/23/2010 (MED 501057P). She advised she had a mild cough with a sore scratchy throat for 2 days prior to this vaccination (exposed to friend with strep throat). By 9/26/2010 (3 days post vaccination) she began to experience a purulent productive cough that would wake her up, sweating, fever (greater than 102), shortness of breath (problems inhaling), and inability to sleep. She presented to nearby hospital the next morning 9/27/2010 (day 4 after FLUMIST vaccine and day 6 for symptom onset) and admitted for Community Acquired Pneumonia (CAP). On 9/29/2010, her respiratory status worsened and she complained of chest pain. She was transferred to hospital for emergent intubation (RR 50-60) being diagnosed with ARDS and multilobar bacterial community acquired pneumonia. She required use of high-frequency oscillatory ventilation, 14 days ceftriaxone and 12 days azithromycin, tracheostomy secondary to tongue angioedema unresponsive to steroids, two right chest tubes secondary to tension pneumothorax, and feeding tubes. On 10/22/2010 she was discharged for inpatient rehab with continued improvement and ultimate resolution of ARDS, multilobe bacterial pneumonia, tongue angioedema, dysphagia, debilitation, and severe malnutrition.
Age: 33.0
Sex: F
Vaccine: FLUN3, FLUN3
Symptoms: Troponin I increased, Ultrasound Doppler normal, White blood cell count increased
Clinical narrative: This is a follow-up to a previously submitted VAERS report unknown, received annual FLUMIST vaccination on 9/23/2010 (MED 501057P). She advised she had a mild cough with a sore scratchy throat for 2 days prior to this vaccination (exposed to friend with strep throat). By 9/26/2010 (3 days post vaccination) she began to experience a purulent productive cough that would wake her up, sweating, fever (greater than 102), shortness of breath (problems inhaling), and inability to sleep. She presented to nearby hospital the next morning 9/27/2010 (day 4 after FLUMIST vaccine and day 6 for symptom onset) and admitted for Community Acquired Pneumonia (CAP). On 9/29/2010, her respiratory status worsened and she complained of chest pain. She was transferred to hospital for emergent intubation (RR 50-60) being diagnosed with ARDS and multilobar bacterial community acquired pneumonia. She required use of high-frequency oscillatory ventilation, 14 days ceftriaxone and 12 days azithromycin, tracheostomy secondary to tongue angioedema unresponsive to steroids, two right chest tubes secondary to tension pneumothorax, and feeding tubes. On 10/22/2010 she was discharged for inpatient rehab with continued improvement and ultimate resolution of ARDS, multilobe bacterial pneumonia, tongue angioedema, dysphagia, debilitation, and severe malnutrition.
Age: 14.0
Sex: F
Vaccine: HPV4, MEN, TTOX
Symptoms: Antinuclear antibody positive, Asthenia, Autoimmune disorder, Blood test, Computerised tomogram
Clinical narrative: Tremors, nausea, light-headed, severe headache, extreme fatigue, mental normalities.
Age: 14.0
Sex: F
Vaccine: HPV4, MEN, TTOX
Symptoms: Dizziness, Fatigue, Headache, Intracranial pressure increased, Lumbar puncture
Clinical narrative: Tremors, nausea, light-headed, severe headache, extreme fatigue, mental normalities.
Age: 14.0
Sex: F
Vaccine: HPV4, MEN, TTOX
Symptoms: Nausea, Nuclear magnetic resonance imaging, Ophthalmological examination, Tremor
Clinical narrative: Tremors, nausea, light-headed, severe headache, extreme fatigue, mental normalities.
Age: 22.0
Sex: F
Vaccine: IPV, RAB
Symptoms: Angioedema, Pyrexia, Urticaria, Vomiting
Clinical narrative: Initial case was received on 16 August 2010 from a healthcare professional.  A 22 year old female patient received on 10 August 2010 an intramuscular injection of IMOVAX Rabies (lot number D1111-1) (pre-exposure series) and a subcutaneous injection of IPOL (lot number E0123-1).  The patient reported to the healthcare professional that she "began to break out in large hives" 4-5 hours post vaccinations.  The healthcare professional reported "angioedema", but the patient was not seen by a healthcare professional at the time of the hives.  The patient got on a flight.  She self medicated with Benadryl 25 mg orally (frequency unknown) and was not evaluated by a physician at any time.  The patient reported that 48-72 hours post vaccination she had a low grade fever (no temperature recorded) and vomited once.  The patient received 2 previous doses of IMOVAX Rabies (lot number D0792-1) on 19 July 2010 and 27 July 2010 with no reactions.  The patient experienced hives post final dose of Japanese encephalitis vaccine in 2007 but none post first 2 doses.  Patient did not have an illness at the time of the vaccinations.  Concomitant medication included Malarone.  The patient is allergic to Bactrim and Cefzil.  No other pre-existing medical conditions were reported.  At the time of this report the outcome status of the adverse events was not reported.  Follow-up information was received 20 September 2010 from a health care professional.  According to the reporter, the patient received corrective treatment with Benadryl x3 and symptoms resolved by the next day.  Outcome was recovered.  Follow-up information was received 12 November 2010 from a health care professional.  The patient experienced one episode of vomiting and the symptoms of hives, angioedema and fever each lasted 24 hours.  No additional information was provided at the time of the report.  Follow-up information received from a health care professional on 29 November 2010.  The patient had hives located on the neck, arms and face.  She experienced no difficulty in breathing during the event.  The patient's fever and vomiting resolved on 12 August 2010.  The patient's date of full recovery was on 12 August 2010.  Follow-up information received from a health care professional on 22 December 2010.  The location of the hives and angioedema was on the trunk and neck.  The patient had no difficulty breathing.  The outcome remained recovered.  This patient had previously experienced another adverse event which has been captured in case number 2010-04404.  Documents held by sender: None.
Age: 57.0
Sex: F
Vaccine: RAB
Symptoms: Hypoaesthesia, Hypoaesthesia facial, Paraesthesia
Clinical narrative: Initial case was received on 05 November 2010 from a healthcare professional. A 57 year old female patient received on 11 July 2010, the second of a series of injections of IMOVAX Rabies with lot number D0869-1, for "possible rabies exposure." The first in the series of injections of IMOVAX Rabies with lot number D0792, had previously been given on 08 July 2010. One week after the IMOVAX vaccination received on 11 July 2010, the patient experienced numbness and tingling of left side of face, body tingling and as of this report experienced numbness and tingling of both arms. She was being treated by a healthcare professional and a neurologist. The patient had "several" prior IMOVAX Rabies vaccinations for past history of "possible rabies exposures" (no dates provided). No pre-existing medical conditions, allergies or concomitant medications were reported. The outcome was not recovered. Follow-up information was received 08 December 2010 from a health care professional who provided contact information for hospital emergency room and the patient's neurologist. No additional information was provided. Follow-up information was received 18 January 2011 from a health care professional. According to the reporter, the etiology of the patient's symptom of persistent numbness and tingling sensation was not clear at this time. No neurological treatment was currently offered for this issue. The reporter further noted that vaccine administration information would have to be obtained from the patient's primary medical provider. No additional information was provided. Follow-up information was received 01 March 2011 from a health care professional. According to the reporter, she had no additional information to provide at this time. The patient's outcome remained not recovered. List of documents held by sender: None.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, PPV
Symptoms: Lethargy, Nausea, Pyrexia, Vomiting
Clinical narrative: fever, nausea, vomiting, lethargy for 2 days
Age: 27.0
Sex: F
Vaccine: TDAP
Symptoms: Hot flush, Nausea, Pyrexia, Vomiting
Clinical narrative: Pt was given Tdap at 11:45AM and at 6:30 PM the same day had nausea, vomiting x 4, hot/cold flashes, fever.  4/21/2011: pt vomited x 1 and still nauseated.  Mother told pt that pt unable to tolerate pertussis as a child and got the vaccine without it.  Pt unaware of information at time of injection.
Age: 29.0
Sex: M
Vaccine: ANTH
Symptoms: Chills, Lymphadenopathy, Nausea, Pain, Pyrexia
Clinical narrative: Fever, chills, nausea, local pain, local lymphadenopathy
Age: 12.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Oedema peripheral, Pruritus
Clinical narrative: Vaccinated approximately 10:30 AM on 05/02/2011 at school.  Child reported to nurse that right arm area swollen and itchy approx 1 hr later.  Ice pack applied to right deltoid area, no itch or rash noted to any other area other than right deltoid.  No SOB or swallowing problems.  Mother informed.  Grandmother arrived to school with Tylenol and Benadryl which was taken about 11:45 AM and child attended school lunch with ice pack.  Principal informed.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash pruritic
Clinical narrative: Intensely itching rash on left buttock went to Ed on 4/9/11 and was given Rx for Valtrex (switched to Famvir)and nupercainal
Age: 40.0
Sex: F
Vaccine: HPV4
Symptoms: Uterine cancer
Clinical narrative: Information has been received from a physician concerning an approximately 40 year old female patient who on an unspecified date was vaccinated with a dose of GARDASIL (lot# not reported).  Subsequently the patient developed uterine cancer.  At the time of reporting, the outcome of uterine cancer was not reported.  It was unspecified if the patient sought medical attention.  Upon internal review, uterine cancer was determined to be an other important medical event.  Additional information has been requested.
Age: 17.0
Sex: F
Vaccine: HPV4
Symptoms: Musculoskeletal pain, Sensory disturbance, Vaccine positive rechallenge
Clinical narrative: The Gardasil shot was giving in the right deltoid. This was her 2nd Gardasil shot. She could feel the medicine travel across her back into her left shoulder & down her side & stop right near her breast. There was pain on her left shoulder & side afterward for about an hour. It's kinda strange how it travels to the opposite side. This happened with the 1st shot also. It just scared us because it was going so close to her heart. She is due a 3rd shot September & we hope it is safe to have it again.
Age: 2.0
Sex: M
Vaccine: PNC
Symptoms: Blood immunoglobulin G decreased, Blood test, Hypersensitivity, Malaise, Urinary tract infection
Clinical narrative: This is a spontaneous report from a contactable consumer (mother) who reported adverse events for PREVNAR in siblings.  This is the first of two reports.  A 2-year-old male patient received the fourth dose of PREVNAR in Jan2005.  Past vaccine history included the first dose on 30Dec2003, the second dose in Feb2004 and the third dose in Jul2004.  Relevant medical history and concomitant medications were unknown.  It was reported that in Jan2005, the child was very sick and was diagnosed with an urine infection.  The patient was reported to have a pneumococcal level in the blood of -1.3(unknown units).  It was also reported that the patient had an allergy and his immunoglobulin (Ig82) was low since an unknown date.  It was reported that the child discontinued the therapy since an unknown date in Jun2005.  Therapeutic measures taken in response to the events were unknown at the time of the report.  The clinical outcome of the reported events was unknown at the time of the report.
Sex: M
Vaccine: PNC
Symptoms: Adenoidectomy, Antibody test abnormal, Asthma, B-lymphocyte count increased, Cellulitis
Clinical narrative: This is an initial spontaneous report from a contactable reporter. This is the second of the two reports by the same reporter. A consumer, the mother of a currently 8-year-old son (race unknown) received a dose of PREVNAR 7 on an unspecified date in Jan2005. The patient had previously received 3 doses PREVNAR on 30-Dec2003, Feb2004 and Jul2004. Concomitant vaccines administered on an unspecified date in 2007, included HIB vaccine, TETANUS and DTAP. Relevant medical history was unknown. On an unspecified date in Mar2006, the patient was diagnosed with a sinus infection. On an unspecified date in Aug2006, the patient experienced cellulitis on the left leg for which he was hospitalized for two days. On an unspecified date in 2006, the patient experienced asthma. On 26-Jan2007, the patient was (term reported as) re-vaccinated with a dose of PNEUMOCOCCAL POLYSACCHARIDE vaccine, reported as a suspect vaccine. On an unspecified date in 2007, the patient had pneumococcal blood work done that showed the level of pneumococcal types 15 and 37 were high after the revaccination, and later after four months (date not specified) the blood work showed that the level of pneumococcal types 3, 4, 8, 19, 26, 57 and 68 had dropped. The patient's B-lymphocyte antigen CD19 showed a high count on an unknown date while receiving PNEUMOCOCCAL-23 vaccine. On an unspecified date, the patient had his adenoids removed. Treatment included amoxicillin (unknown dose and frequency). Treatment was administered on unspecified dates when the patient's pneumococcal types 3, 4, 8, 9, 19, 26, 57, and 68 went down (2007) and additionally, the patient was treated (dates not specified) with an unspecified antibiotic for asthma. The clinical outcome of the reported events was unknown at the time of the report.
Sex: M
Vaccine: PNC
Symptoms: Sinusitis
Clinical narrative: This is an initial spontaneous report from a contactable reporter. This is the second of the two reports by the same reporter. A consumer, the mother of a currently 8-year-old son (race unknown) received a dose of PREVNAR 7 on an unspecified date in Jan2005. The patient had previously received 3 doses PREVNAR on 30-Dec2003, Feb2004 and Jul2004. Concomitant vaccines administered on an unspecified date in 2007, included HIB vaccine, TETANUS and DTAP. Relevant medical history was unknown. On an unspecified date in Mar2006, the patient was diagnosed with a sinus infection. On an unspecified date in Aug2006, the patient experienced cellulitis on the left leg for which he was hospitalized for two days. On an unspecified date in 2006, the patient experienced asthma. On 26-Jan2007, the patient was (term reported as) re-vaccinated with a dose of PNEUMOCOCCAL POLYSACCHARIDE vaccine, reported as a suspect vaccine. On an unspecified date in 2007, the patient had pneumococcal blood work done that showed the level of pneumococcal types 15 and 37 were high after the revaccination, and later after four months (date not specified) the blood work showed that the level of pneumococcal types 3, 4, 8, 19, 26, 57 and 68 had dropped. The patient's B-lymphocyte antigen CD19 showed a high count on an unknown date while receiving PNEUMOCOCCAL-23 vaccine. On an unspecified date, the patient had his adenoids removed. Treatment included amoxicillin (unknown dose and frequency). Treatment was administered on unspecified dates when the patient's pneumococcal types 3, 4, 8, 9, 19, 26, 57, and 68 went down (2007) and additionally, the patient was treated (dates not specified) with an unspecified antibiotic for asthma. The clinical outcome of the reported events was unknown at the time of the report.
Age: 95.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Pain
Clinical narrative: Patient received high dose of influenza vaccine in left deltoid in usual manner on 10/26/2010 in our office. Since then she has complained of chronic, severe pain in upper left arm. Orthopedist consultation has revealed no other cause for pain. This is being reported only now, because it seems clear now that this pain is unusual in length and intensity from any pain experienced after any other injection in our physician's 17 year practice of medicine. Product was FLUZONE HIGH DOSE Sanofi Pasteur U3599AA 30 Jun 11 0.5 ml.
Age: 21.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Culture wound, Exposure to vaccinated person, Viral infection
Clinical narrative: To the best of my knowledge I contracted this virus through someone laying on my bunk and having their shot area exposed and then I laid on that same spot.
Age: 21.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Orthopoxvirus test positive, Polymerase chain reaction, Skin lesion
Clinical narrative: To the best of my knowledge I contracted this virus through someone laying on my bunk and having their shot area exposed and then I laid on that same spot.
Age: 59.0
Sex: F
Vaccine: HEP
Symptoms: Asthenia, Chest X-ray normal, Cough, Dysphonia, Dyspnoea
Clinical narrative: I have just completed the hepatitis AB-A-AB shot program. My last AB shot was 4/28. Midday on 5/1 I was suddenly unable to breathe properly -SOB- and felt very weak, voice hoarse and wheezing with a phlegmy cough developed. So why am I writing you. I had my first AB shot on 9/14, my second A shot on 10/15. On 12/2 I woke up unable to breathe properly and my health declined. I presented myself to the free clinic - I have no insurance/job- and they have been trying to determine what is wrong with me. A chest XRay ruled out lung problems, now they are focusing on my heart. When I got that shot and 2 days later my health further declined & repeated what had happened in December - I didn't think it a coincidence! My persistent but almost gone cough reappeared and I found myself stumbling around...I thought I would investigate adverse reactions to Hep B. Sure enough, I have those reactions!! This realization probably won't help my health any but I hope it will bring this to your attention.
Age: 59.0
Sex: F
Vaccine: HEP
Symptoms: Gait disturbance, General physical health deterioration, Hyperthyroidism, Serum ferritin increased, Wheezing
Clinical narrative: I have just completed the hepatitis AB-A-AB shot program. My last AB shot was 4/28. Midday on 5/1 I was suddenly unable to breathe properly -SOB- and felt very weak, voice hoarse and wheezing with a phlegmy cough developed. So why am I writing you. I had my first AB shot on 9/14, my second A shot on 10/15. On 12/2 I woke up unable to breathe properly and my health declined. I presented myself to the free clinic - I have no insurance/job- and they have been trying to determine what is wrong with me. A chest XRay ruled out lung problems, now they are focusing on my heart. When I got that shot and 2 days later my health further declined & repeated what had happened in December - I didn't think it a coincidence! My persistent but almost gone cough reappeared and I found myself stumbling around...I thought I would investigate adverse reactions to Hep B. Sure enough, I have those reactions!! This realization probably won't help my health any but I hope it will bring this to your attention.
Age: 48.0
Sex: F
Vaccine: FLUX
Symptoms: Acute disseminated encephalomyelitis, Influenza like illness, Nervous system disorder, Nuclear magnetic resonance imaging
Clinical narrative: Pt developed ADEM - neurologic illness like multiple sclerosis. Had flu-like sx shortly after rec'd flu vaccine.
Age: 12.0
Sex: F
Vaccine: HPV4, MNQ, VARCEL
Symptoms: Injection site erythema, Injection site rash, Injection site swelling, Pyrexia
Clinical narrative: (L) arm red, swollen with a rash around injection site, with fever.
Age: 42.0
Sex: F
Vaccine: TDAP
Symptoms: Axillary pain, Hypoaesthesia, Injection site pain, Nodule, Paraesthesia
Clinical narrative: Soreness/knot under armpit, tingling/numbness in hand, injection site still sore after 5 days.
Age: 55.0
Sex: F
Vaccine: PPV
Symptoms: Injected limb mobility decreased, Injection site pain, Paraesthesia
Clinical narrative: (R) shoulder pain, severe; tingling sensation along (R) arm; not able to rise (R) arm.
Age: 36.0
Sex: F
Vaccine: TDAP
Symptoms: Joint range of motion decreased, Pain
Clinical narrative: 4/5/11 Tdap. 4/6/11 localized pain decreased ROM of (L) arm.
Age: 0.82
Sex: M
Vaccine: DTAP, PNC13
Symptoms: Crying, Death, Decreased appetite, Infantile spitting up, Pyrexia
Clinical narrative: He was administered the shot and by the next day started having fevers & spitting up his food. His fever got worse and his appetite also. He was sleeping & crying for the most part and his fever was being stabilized by MOTRIN and TYLENOL.
Age: 0.82
Sex: M
Vaccine: DTAP, PNC13
Symptoms: Somnolence
Clinical narrative: He was administered the shot and by the next day started having fevers & spitting up his food. His fever got worse and his appetite also. He was sleeping & crying for the most part and his fever was being stabilized by MOTRIN and TYLENOL.
Age: 0.16
Sex: M
Vaccine: DTAP, HIBV, PNC13, RV5
Symptoms: Irritability, Pallor
Clinical narrative: 20 minutes fussiness noticeable pallor (after awakening from nap).
Age: 38.0
Sex: F
Vaccine: TDAP
Symptoms: Erythema, Oedema peripheral, Skin warm
Clinical narrative: Noted redness, warmth, swelling (R) arm 5/3/11 in evening. Seen in PCP office 5/4/11. Txed with IM steroid, PO steroid taper, antihistamine.
Age: 58.0
Sex: M
Vaccine: PPV
Symptoms: Erythema, Local swelling, Tenderness
Clinical narrative: (L) arm - localized swelling & redness slightly tender.
Age: 42.0
Sex: M
Vaccine: ANTH
Symptoms: Injection site erythema, Injection site pruritus, Injection site reaction, Musculoskeletal stiffness, Pain
Clinical narrative: Localized pain, swelling, muscle stiffness, itchiness, and redness around vaccination site.
Age: 42.0
Sex: M
Vaccine: ANTH
Symptoms: Pruritus, Vaccination site pain, Vaccination site swelling
Clinical narrative: Localized pain, swelling, muscle stiffness, itchiness, and redness around vaccination site.
Age: 12.0
Sex: F
Vaccine: TDAP
Symptoms: Anxiety, Dizziness, Malaise, Nervousness
Clinical narrative: Pt was extremely apprehensive about receiving the shot, but cooperative. When pt received her shot she appeared fine so she was sent back to class. 15-20 min after she returned to class the RN was called to go see her at her classroom because she was unwell, per RN pt was "light headed" and "Dizzy". Pt admitted being "super nervous" vitals were normal. RN had pt elevate her feet, take deep breath and drink water and within 10 min pt felt "fine".
Age: 71.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site urticaria, Skin discolouration
Clinical narrative: Patient developed a wheal at injection site. Slight nodule possible. Hasn't worsened since Tuesday. Recommended ice, TYLENOL/Ibuprofen, Antihistamine, and HC cream if necessary. Follow up with physician if no improvement. No fever or warm to the touch of area. Small black/blue mark below shot.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Disorientation, Headache, Oedema peripheral
Clinical narrative: Approximately 6 hrs. after administration of shingles vaccine (after store closing) - severe headache, swollen arm & disorientation for about 24 hrs.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Rash
Clinical narrative: Rashes around both eyes few minutes after receiving vaccines, no shortness of breath.
Age: 20.0
Sex: F
Vaccine: VARCEL
Symptoms: Erythema, Swelling, Tenderness
Clinical narrative: Redness, swelling, tenderness near injection site.
Age: 16.0
Sex: F
Vaccine: MNQ
Symptoms: Erythema, Induration, Nodule, Oedema peripheral, Skin warm
Clinical narrative: Swelling of the arm, and hardness of the upper arm. The arm got very hot and red. "Bumpy" under the skin.
Age: 13.0
Sex: F
Vaccine: HPV4
Symptoms: Erythema, Pain in extremity, Rash, Streptococcus test, Streptococcus test negative
Clinical narrative: Patient developed painful bumps under skin on legs now turned red. Symptoms started 10-14 days after immunization.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: (R) arm rx to Imm. Slight tender, swollen, red. Pt given ABX & topical cream.
Age: 3.0
Sex: M
Vaccine: PNC13
Symptoms: Erythema, Injection site erythema, Pallor, Skin lesion
Clinical narrative: Red blanching annular lesions on legs, chest, hands, buttocks - started at vaccine site.
Age: 11.0
Sex: M
Vaccine: HPV4
Symptoms: Excessive eye blinking, Tic
Clinical narrative: "Facial tics" - rapid blinking which was controllable by patient but lasted x several days.
Age: 14.0
Sex: M
Vaccine: HEPA, MNQ, TDAP, VARCEL
Symptoms: Petechiae
Clinical narrative: Patient developed petechia on left arm.
Age: 1.6
Sex: F
Vaccine: DTAP, HIBV
Symptoms: Injection site cellulitis
Clinical narrative: Cellulitis at injection site within 24hrs.
Age: 46.0
Sex: M
Vaccine: HEPA, YF
Symptoms: Hypersomnia, Insomnia
Clinical narrative: Client reported to me on 5/4/11 that he was hypersomulent for 3 days after a Hepatitis A (Havrix) and Yellow Fever vaccine. Now he reports has had insomnia since 4 days after vaccines. No treatment.
Age: 0.38
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5
Symptoms: Computerised tomogram abdomen abnormal, Intussusception, Irritability, Small intestinal obstruction, Ultrasound abdomen abnormal
Clinical narrative: Began 04/07-08/2011 Irritable, fussy, multiple episodes of emesis with bilious and some projectile vomiting, decreased urine output.
Age: 0.38
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5
Symptoms: Urine output decreased, Vomiting, Vomiting projectile
Clinical narrative: Began 04/07-08/2011 Irritable, fussy, multiple episodes of emesis with bilious and some projectile vomiting, decreased urine output.
Age: 0.38
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5
Symptoms: Abdominal X-ray, Abdominal distension, Appendicectomy, Atelectasis, Band neutrophil count
Clinical narrative: Began 04/07-08/2011 Irritable, fussy, multiple episodes of emesis with bilious and some projectile vomiting, decreased urine output.
Age: 0.38
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5
Symptoms: Bradycardia, C-reactive protein increased, Chest X-ray abnormal, Computerised tomogram abdomen abnormal, Condition aggravated
Clinical narrative: Began 04/07-08/2011 Irritable, fussy, multiple episodes of emesis with bilious and some projectile vomiting, decreased urine output.
Age: 0.38
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5
Symptoms: Cough, Dehydration, Diverticulectomy, Echocardiogram normal, Enema administration
Clinical narrative: Began 04/07-08/2011 Irritable, fussy, multiple episodes of emesis with bilious and some projectile vomiting, decreased urine output.
Age: 0.38
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5
Symptoms: Explorative laparotomy, Gastrointestinal disorder, Haematochezia, Haematocrit decreased, Haemoglobin decreased
Clinical narrative: Began 04/07-08/2011 Irritable, fussy, multiple episodes of emesis with bilious and some projectile vomiting, decreased urine output.
Age: 0.38
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5
Symptoms: Hypophagia, Ileectomy, Ileus, Intestinal dilatation, Intestinal functional disorder
Clinical narrative: Began 04/07-08/2011 Irritable, fussy, multiple episodes of emesis with bilious and some projectile vomiting, decreased urine output.
Age: 0.38
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5
Symptoms: Intussusception, Irritability, Laboratory test abnormal, Lung disorder, Nasal congestion
Clinical narrative: Began 04/07-08/2011 Irritable, fussy, multiple episodes of emesis with bilious and some projectile vomiting, decreased urine output.
Age: 0.38
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5
Symptoms: Neutrophil count abnormal, Neutrophil count decreased, Neutrophil percentage decreased, Peritonitis, Platelet count increased
Clinical narrative: Began 04/07-08/2011 Irritable, fussy, multiple episodes of emesis with bilious and some projectile vomiting, decreased urine output.
Age: 0.38
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5
Symptoms: Post procedural complication, Post procedural sepsis, Pyrexia, Respiratory failure, Small intestinal anastomosis
Clinical narrative: Began 04/07-08/2011 Irritable, fussy, multiple episodes of emesis with bilious and some projectile vomiting, decreased urine output.
Age: 0.38
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5
Symptoms: Small intestinal obstruction, Somnolence, Systemic inflammatory response syndrome, Tachycardia, Ultrasound abdomen abnormal
Clinical narrative: Began 04/07-08/2011 Irritable, fussy, multiple episodes of emesis with bilious and some projectile vomiting, decreased urine output.
Age: 0.38
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5
Symptoms: Urine output decreased, Vitello-intestinal duct remnant, Vomiting, Vomiting projectile, White blood cell count normal
Clinical narrative: Began 04/07-08/2011 Irritable, fussy, multiple episodes of emesis with bilious and some projectile vomiting, decreased urine output.
Age: 0.38
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5
Symptoms: X-ray abnormal
Clinical narrative: Began 04/07-08/2011 Irritable, fussy, multiple episodes of emesis with bilious and some projectile vomiting, decreased urine output.
Age: 0.38
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5
Symptoms: Abdominal X-ray, Abdominal distension, Appendicectomy, Atelectasis, Band neutrophil percentage
Clinical narrative: Began 04/07-08/2011 Irritable, fussy, multiple episodes of emesis with bilious and some projectile vomiting, decreased urine output.
Age: 0.38
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5
Symptoms: Body temperature increased, Bradycardia, C-reactive protein increased, Chest X-ray abnormal, Computerised tomogram abnormal
Clinical narrative: Began 04/07-08/2011 Irritable, fussy, multiple episodes of emesis with bilious and some projectile vomiting, decreased urine output.
Age: 0.38
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5
Symptoms: Cough, Diverticulectomy, Echocardiogram normal, Enema administration, Haematochezia
Clinical narrative: Began 04/07-08/2011 Irritable, fussy, multiple episodes of emesis with bilious and some projectile vomiting, decreased urine output.
Age: 0.38
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5
Symptoms: Haematocrit, Haemoglobin decreased, Hypophagia, Ileectomy, Ileus
Clinical narrative: Began 04/07-08/2011 Irritable, fussy, multiple episodes of emesis with bilious and some projectile vomiting, decreased urine output.
Age: 0.38
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5
Symptoms: Intestinal anastomosis, Intestinal dilatation, Intestinal prolapse, Intussusception, Irritability
Clinical narrative: Began 04/07-08/2011 Irritable, fussy, multiple episodes of emesis with bilious and some projectile vomiting, decreased urine output.
Age: 0.38
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5
Symptoms: Lung disorder, Nasal congestion, Neutrophil percentage decreased, Peritonitis, Platelet count increased
Clinical narrative: Began 04/07-08/2011 Irritable, fussy, multiple episodes of emesis with bilious and some projectile vomiting, decreased urine output.
Age: 0.38
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5
Symptoms: Respiratory failure, Sepsis, Small intestinal obstruction, Somnolence, Systemic inflammatory response syndrome
Clinical narrative: Began 04/07-08/2011 Irritable, fussy, multiple episodes of emesis with bilious and some projectile vomiting, decreased urine output.
Age: 0.38
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5
Symptoms: Tachycardia, Urine output decreased, Vitello-intestinal duct remnant, Vomiting, Vomiting projectile
Clinical narrative: Began 04/07-08/2011 Irritable, fussy, multiple episodes of emesis with bilious and some projectile vomiting, decreased urine output.
Age: 0.38
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5, DTAP, HIBV, IPV, PNC13, RV5
Symptoms: White blood cell count normal, X-ray abnormal
Clinical narrative: Began 04/07-08/2011 Irritable, fussy, multiple episodes of emesis with bilious and some projectile vomiting, decreased urine output.
Age: 24.0
Sex: F
Vaccine: SMALL
Symptoms: Rash
Clinical narrative: RASH
Age: 22.0
Sex: F
Vaccine: TDAP
Symptoms: Fatigue, Injection site pruritus, Injection site urticaria, Pruritus, Pyrexia
Clinical narrative: "Hives on body - from right wrist along length of right arm, on right side of trunk to belly button", itchiness for two to three days; also felt exhausted for two days, and on 5/2/11 had a fever of 101 or 102 degrees.
Age: 22.0
Sex: F
Vaccine: TDAP
Symptoms: Urticaria
Clinical narrative: "Hives on body - from right wrist along length of right arm, on right side of trunk to belly button", itchiness for two to three days; also felt exhausted for two days, and on 5/2/11 had a fever of 101 or 102 degrees.
Age: 5.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site pain, Injection site swelling, Pyrexia, Rash pruritic
Clinical narrative: Pain at injection site and slight swelling, fever, large rash itchy rash near injection site.
Age: 48.0
Sex: F
Vaccine: MMR, PPV, TDAP
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Redness and swelling of the left upper arm bicep area for one day c/o tenderness with palpation, afebrile, no redness or swelling noted at injection site.
Age: 0.18
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV1
Symptoms: Anion gap increased, Antibiotic resistant Staphylococcus test, Bacterial test negative, Blood bicarbonate decreased, Blood chloride normal
Clinical narrative: This male subject was enrolled in the prophylactic study 112957 (HIB-097).  On 28 March 2011, he received the 1st dose of HIBERIX (IM R thigh), PEDIARIX (IM L thigh), Wyeth's PREVNAR 13 (IM L thigh or deltoid) and ROTARIX (po).  On 11 April 2011, 14 days after the 1st dose of PEDIARIX, 14 days after the 1st dose of ROTARIX, 14 days after the 1st dose of HIBERIX, 14 days after the 1st dose of PREVNAR 13, this two-month-old subject developed seizure.  The subject was hospitalised.  The subject was treated with lorazepam and phenobarbitone.  The event resolved on 11 April 2011.  The investigator considered that there was a reasonable possibility that the seizure may have been caused by PEDIARIX, ROTARIX, HIBERIX and PREVNAR 13.  Investigator Comments : CT head w/o contrast=grossly normal with no acute intracraneal pathology.  Electroencephalogram=normal for stated age.  MRI Brain without and with contrast = Very subtile periventricular white matter T2 hyperintensity is noted.  This likely related to patients age and related to phase of myelination.  No midline shift, mass effect or abnormal enhancement is identified.  11APR2011-MRSA culture- No methicillin resistant staph aureus isolated.  19APR2011-He was doing well at home until after feeding he turned blue around mouth and started grunting, head turned to left side and left arm and leg noted to be stiff.  Taken to Emergency Department where he had one afrebile seizure lasting 20-30 min with left sided stiffness.  He received 3 doses Lorazepam, 1 fluid bolus and 1 loading dose of Phenobarbital, which broke his seizure.  Transferred to PICU for further management and observation.  No further seizure activity.